ABBV•benzinga•
AbbVie Raises Profit Outlook But Flags Tariff Risks In Pharma Sector
Summary
AbbVie stock climbs after Q1 earnings beat and 2025 EPS forecast raise; strong growth in immunology and neuroscience portfolios led the results.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 25, 2025 by benzinga